Skip to main content
Top
Published in: Inflammation 6/2007

01-12-2007

Inner Anti-inflammatory Mechanisms of Petroleum Ether Extract from Melilotus suaveolens Ledeb

Authors: Lei Zhao, Jun-Yan Tao, Shu-Ling Zhang, Ran Pang, Feng Jin, Ji-Hua Dong, Yuan-Jin Guo

Published in: Inflammation | Issue 6/2007

Login to get access

Abstract

Summary

Melilotus suaveolens Ledeb is a species of traditional medical plant for treating inflammation-related disease. This study is to explore the inner anti-inflammatory mechanism on petroleum ether extract from Melilotus suaveolens Ledeb.

Materials and Methods

Inflammatory cellular model was founded by intervention of lipopolysaccharide (LPS) on RAW264.7 cell line. Secretion of TNF-α, IL-1β, IL-6, NO and IL-10 in supernatant, mRNA expression of TNF-α, COX-2, iNOS and HO-1, protein expression of COX-2 and HO-1, activation of NF-κB and ingredients in the extract were assayed.

Results

The extract could not only reduce production of pro-inflammatory mediators by blocking NF-κB activation but promote release of anti-inflammatory mediator HO-1 significantly. The only active ingredient in the extract was coumarin and the concentration of coumarin in each 1 g extract was 0.27822 mg.

Conclusion

Compared to Dexamethasone, the extract not only has similar effects on antagonizing pro-inflammatory mediators and cytokines but has effects on promoting production of anti-inflammatory mediators.
Literature
1.
go back to reference Plesca-Manea, L., A. E. Parvu, M. Parvu, M. Taamas, R. Buia, and M. Puia. 2002. Effects of Melilotus officinalis on acute inflammation. Phytother. Res. 16:316–319.PubMedCrossRef Plesca-Manea, L., A. E. Parvu, M. Parvu, M. Taamas, R. Buia, and M. Puia. 2002. Effects of Melilotus officinalis on acute inflammation. Phytother. Res. 16:316–319.PubMedCrossRef
2.
go back to reference Kim, K. M., Y. G. Kwon, H. T. Chung, Y. G. Yun, H. O. Pae, J. A. Han, K. S. Ha, T. W. Kim, and Y. M. Kim. 2003. Methanol extract of Cordyceps pruinosa inhibits in vitro and in vivo inflammatory mediators by suppressing NF-kappaB activation. Toxicol. Appl. Pharmacol. 190:1–8.PubMedCrossRef Kim, K. M., Y. G. Kwon, H. T. Chung, Y. G. Yun, H. O. Pae, J. A. Han, K. S. Ha, T. W. Kim, and Y. M. Kim. 2003. Methanol extract of Cordyceps pruinosa inhibits in vitro and in vivo inflammatory mediators by suppressing NF-kappaB activation. Toxicol. Appl. Pharmacol. 190:1–8.PubMedCrossRef
3.
go back to reference Shao, B. M., W. Xu, H. Dai, P. Tu, Z. Li, and X. M. Gao. 2004. A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem. Biophys. Res. Commun. 320:1103–1111.PubMedCrossRef Shao, B. M., W. Xu, H. Dai, P. Tu, Z. Li, and X. M. Gao. 2004. A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem. Biophys. Res. Commun. 320:1103–1111.PubMedCrossRef
4.
go back to reference Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408.PubMedCrossRef Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408.PubMedCrossRef
5.
go back to reference Qi, L. W., Q. T. Yu, P. Li, S. L. Li, Y. X. Wang, L. H. Sheng, and L. Yi. 2006. Quality evaluation of Radix Astragali through a simultaneous determination of six major active isoflavonoids and four main saponins by high-performance liquid chromatography coupled with diode array and evaporative light scattering detectors. J. Chromatogr. A 1134:162–169.PubMedCrossRef Qi, L. W., Q. T. Yu, P. Li, S. L. Li, Y. X. Wang, L. H. Sheng, and L. Yi. 2006. Quality evaluation of Radix Astragali through a simultaneous determination of six major active isoflavonoids and four main saponins by high-performance liquid chromatography coupled with diode array and evaporative light scattering detectors. J. Chromatogr. A 1134:162–169.PubMedCrossRef
6.
go back to reference Zoltan, O. T., and M. Foldi. 1970. Effect of coumarin from Melilotus officinalis on the convulsion threshold of the central nervous system in rats and guinea pigs. Arzneim.-Forsch. 20:1625. Zoltan, O. T., and M. Foldi. 1970. Effect of coumarin from Melilotus officinalis on the convulsion threshold of the central nervous system in rats and guinea pigs. Arzneim.-Forsch. 20:1625.
7.
go back to reference Pastura, G., M. Mesiti, M. Saitta, D. Romeo, N. Settineri, R. Maisano, M. Petix, and A. Giudice. 1999. Lymphedema of the upper extremity in patients operated for carcinoma of the breast: clinical experience with coumarinic extract from Melilotus officinalis. Clin. Ter. 150:403–408.PubMed Pastura, G., M. Mesiti, M. Saitta, D. Romeo, N. Settineri, R. Maisano, M. Petix, and A. Giudice. 1999. Lymphedema of the upper extremity in patients operated for carcinoma of the breast: clinical experience with coumarinic extract from Melilotus officinalis. Clin. Ter. 150:403–408.PubMed
8.
go back to reference Podkolzin, A. A., V. I. Dontsov, I. A. Sychev, G. YU. Kobeleva, and O. N. Kharchenko. 1996. Immunocorrecting, antianemia, and adaptogenic effects of polysaccharides from Melilotus officinalis. Biull. Eksp. Biol. Med. 121:661–663.PubMedCrossRef Podkolzin, A. A., V. I. Dontsov, I. A. Sychev, G. YU. Kobeleva, and O. N. Kharchenko. 1996. Immunocorrecting, antianemia, and adaptogenic effects of polysaccharides from Melilotus officinalis. Biull. Eksp. Biol. Med. 121:661–663.PubMedCrossRef
10.
go back to reference Tsatsanis, C., A. Androulidaki, M. Venihaki, and A. N. Margioris. 2006. Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell. Biol. 38:1654–1661.PubMedCrossRef Tsatsanis, C., A. Androulidaki, M. Venihaki, and A. N. Margioris. 2006. Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell. Biol. 38:1654–1661.PubMedCrossRef
11.
go back to reference Korhonen, R., A. Lahti, H. Kankaanranta, and E. Moilanen. 2005. Nitric oxide production and signaling in inflammation. Curr. Drug Targets Inflamm. Allergy 4:471–479.PubMedCrossRef Korhonen, R., A. Lahti, H. Kankaanranta, and E. Moilanen. 2005. Nitric oxide production and signaling in inflammation. Curr. Drug Targets Inflamm. Allergy 4:471–479.PubMedCrossRef
12.
go back to reference Aggarwal, B. B., S. Shishodia, S. K. Sandur, M. K. Pandey, and G. Sethi. 2006. Inflammation and cancer: how hot is the link? Biochem. Pharmacol. 72:1605–1621.PubMedCrossRef Aggarwal, B. B., S. Shishodia, S. K. Sandur, M. K. Pandey, and G. Sethi. 2006. Inflammation and cancer: how hot is the link? Biochem. Pharmacol. 72:1605–1621.PubMedCrossRef
13.
go back to reference Harizi, H., and N. Gualde. 2006. Pivotal role of PGE2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators. Cell. Mol. Immunol. 3:271–277.PubMed Harizi, H., and N. Gualde. 2006. Pivotal role of PGE2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators. Cell. Mol. Immunol. 3:271–277.PubMed
14.
go back to reference Abraham, N. G., A. Asija, G. Drummond, and S. Peterson. 2007. Heme oxygenase-1 gene therapy: recent advances and therapeutic applications. Curr Gene Ther. 7:89–108.PubMedCrossRef Abraham, N. G., A. Asija, G. Drummond, and S. Peterson. 2007. Heme oxygenase-1 gene therapy: recent advances and therapeutic applications. Curr Gene Ther. 7:89–108.PubMedCrossRef
15.
go back to reference Prawan, A., J. K. Kundu, and Y. J. Surh. 2005. Molecular basis of heme oxygenase-1 induction: implications for chemoprevention and chemoprotection. Antioxid. Redox Signal. 7:1688–1703.PubMedCrossRef Prawan, A., J. K. Kundu, and Y. J. Surh. 2005. Molecular basis of heme oxygenase-1 induction: implications for chemoprevention and chemoprotection. Antioxid. Redox Signal. 7:1688–1703.PubMedCrossRef
16.
go back to reference Franchimont, D., H. Martens, M. T. Hagelstein, E. Louis, W. Dewe, G. P. Chrousos, J. Belaiche, and V. Geenen. 1999. Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J. Clin. Endocrinol. Metab. 84:2834–2839.PubMedCrossRef Franchimont, D., H. Martens, M. T. Hagelstein, E. Louis, W. Dewe, G. P. Chrousos, J. Belaiche, and V. Geenen. 1999. Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J. Clin. Endocrinol. Metab. 84:2834–2839.PubMedCrossRef
17.
go back to reference Hoult, J. R., and M. Paya. 1996. Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen. Pharmacol. 27:713–722.PubMed Hoult, J. R., and M. Paya. 1996. Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen. Pharmacol. 27:713–722.PubMed
18.
go back to reference Fylaktakidou, K. C., D. J. Hadjipavlou-Litina, K. E. Litinas, and D. N. Nicolaides. 2004. Natural and synthetic coumarin derivatives with anti-inflammatory/ antioxidant activities. Curr. Pharm. Des. 10:3813–3833.PubMedCrossRef Fylaktakidou, K. C., D. J. Hadjipavlou-Litina, K. E. Litinas, and D. N. Nicolaides. 2004. Natural and synthetic coumarin derivatives with anti-inflammatory/ antioxidant activities. Curr. Pharm. Des. 10:3813–3833.PubMedCrossRef
Metadata
Title
Inner Anti-inflammatory Mechanisms of Petroleum Ether Extract from Melilotus suaveolens Ledeb
Authors
Lei Zhao
Jun-Yan Tao
Shu-Ling Zhang
Ran Pang
Feng Jin
Ji-Hua Dong
Yuan-Jin Guo
Publication date
01-12-2007
Publisher
Springer US
Published in
Inflammation / Issue 6/2007
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-007-9039-x

Other articles of this Issue 6/2007

Inflammation 6/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.